Rebecca Sprague

Statistics

Publications

Citations

220

H-Index

Active since

2006

Affiliations

Beth Israel Deaconess Medical Center(Current)

Harvard University

Boston Children's Hospital

University of Houston

bioMérieux (France)

Rebecca Sprague is an author at Beth Israel Deaconess Medical Center specializing in host-pathogen interactions, microbiome, and clinical microbiology.

ORCID

Top concepts

MedicineImmunologyMicrobiomeMicrobiologyPathogenesisPathogenicityInfection ControlClinical MicrobiologyMicrobial PathogenesisHost-pathogen Interactions

Publications per year

2006–2022

Publications

Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial

Gert Van Assche, William J. Sandborn, Brian G. Feagan et al. · Gut · 2006 · 146 citations · Full text

Fecal Mycobiota Combined With Host Immune Factors Distinguish Clostridioides difficile Infection From Asymptomatic Carriage

Yangchun Cao, Lamei Wang, Shanlin Ke et al. · Gastroenterology · 2021 · 38 citations · Full text

Medical Microbiology, Pathogenicity, Dysbiosis +12

Ultrasensitive and Quantitative Toxin Measurement Correlates With Baseline Severity, Severe Outcomes, and Recurrence Among Hospitalized Patients With <i>Clostridioides difficile</i> Infection

Carolyn D. Alonso, Ciarán P. Kelly, Kevin W. Garey et al. · Clinical Infectious Diseases · 2021 · 21 citations · Full text

Stool Interleukin-1β Differentiates <i>Clostridioides difficile</i> Infection (CDI) From Asymptomatic Carriage and Non-CDI Diarrhea

Javier Villafuerte-Gálvez, Nira R. Pollock, Carolyn D. Alonso et al. · Clinical Infectious Diseases · 2022 · 15 citations · Full text

1–4 of 4